Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Non-comparative, Multi-centre Study to Assess the Efficacy and Safety of Bicalutamide When Used in Combination With Anastrozole for the Treatment of Gonadotropin-independent Precocious Puberty in Boys With Testotoxicosis

NCT00094328 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00094328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00094328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Non-comparative, Multi-centre Study to Assess the Efficacy and Safety of Bicalutamide When Used in Combination With Anastrozole for the Treatment of Gonadotropin-independent Precocious Puberty in Boys With Testotoxicosis
Lead sponsor
AstraZeneca
Phase
Phase 2
Overall status
Completed
Start date
November 22, 2004
Completion date
December 6, 2017
Enrollment
14 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

puberty, precocious